Qube Research & Technologies (QRT)’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-64,696
Closed -$4.02M 5002
2023
Q4
$4.02M Buy
64,696
+50,396
+352% +$1.25M 0.01% 1160
2023
Q3
$317K Buy
+14,300
New +$300K ﹤0.01% 2221

Qube Research & Technologies (QRT)'s RYZB Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 64,696 shares — an estimated $4.02M sold.

Qube Research & Technologies (QRT) first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $4.02M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 64,696 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $4.02M.
  • Qube Research & Technologies (QRT) first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s RayzeBio, Inc. Common Stock position peaked at $4.02M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.